Anti-L-selectin Reference Antibody (Aselizumab)
Safety Data Sheet (SDS) - Chemical Safety Information
Product Identification
More information about Anti-L-selectin Reference Antibody (Aselizumab)Basic Product Information
Regulatory Identifiers
N/A
Chemical Abstracts Service registry number - unique identifier for chemical substances
Uses Information
Overview
Anti-L-selectin Reference Antibody (Aselizumab) is a aqueous solution substance commonly used for research use only..
Manage Your Safety Data Sheets
Organize and access your chemical safety data with ease.
Hazard Identification
More about safety measuresClassification Status
Not Classified
This substance does not meet the classification criteria to be listed as a hazardous material according to the EC Directives 67/548/EEC, 1999/45/EC, 1272/2008.
Signal Word
N/A
Hazard Statements
Precautionary Statements
Suppliers & Organizations
Boster Biological Technology Co., Ltd.
manufacturer
📍
3942 B Valley Ave, Pleasanton, CA, 94566, USA.
🌍
US
📞
(888) 466-3604
📠
(925) 215-2184
Emergency Contacts
Similar Substances
A
Anti-SLC1A5 / ASCT2 Reference Antibody (idactamab)
No identifier available
A
Anti-IL-1RL2 / IL-36R Reference Antibody (spesolimab)
No identifier available
A
Anti-ICAM1 / CD54 Reference Antibody (Enlimomab)
No identifier available
A
Anti-IL-4 Reference Antibody (pascolizumab)
No identifier available
A
Anti-CD200 Reference Antibody (samalizumab)
No identifier available
A
Anti-EphA2 Reference Antibody (MEDI-547)
No identifier available
A
Anti-LILRB4 / ILT3 / CD85k Reference Antibody (U.Texas patent anti-LILRB4)
No identifier available
A
Anti-CSF1R / M-CSFR / CD115 Reference Antibody (LY3022855)
No identifier available
Physical & Chemical Properties
More about propertiesFrequently Asked Questions
View full documentationWhat is Anti-L-selectin Reference Antibody (Aselizumab) used for?
For research use only.
What is the melting point of Anti-L-selectin Reference Antibody (Aselizumab)?
The melting point is no data available and the boiling point is no data available.